Steven Lubitz

Director in Translational Medicine
Novartis Institutes for Biomedical Research
Boston, Massachusetts, United States

Presentation(s):

• OC 17.4 - Determining the Risk of Thrombosis in Double Heterozygous Carriers of Factor V Leiden and Prothrombin G20210A Mutation Using Population-Scale Genomics

  Sunday, June 25, 2023
  11:30 – 11:45 ET